Oral Rehydration Salts Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
In many underdeveloped nations, acute diarrheal illnesses rank among the most common causes of infant and neonatal mortality. Additionally, people fromall age groups can be affected and most severe cases of, dehydration from diarrhea can be treated easily, affordably, and simply by giving patients a good glucose-electrolyte solution called oral rehydration salts (ORS) solution orally. The World Health Organisation (WHO) and the United Nations Children's Fund advise using oral rehydration therapy (ORS), a glucose-based salt solution, to treat or prevent diarrhea-related dehydration. This solution has an osmolarity of 245 mOsm/l and includes 75 mmol/l of glucose and 75 mEq/l of sodium. However, ORS can cause side effects, including vomiting, high blood potassium, and high blood salt levels.
Since 2003, WHO and UNICEF have encouraged using a new ORS formulation that is more effective than the previous formulation. The WHO Expert Committee on specifications forpharmaceutical preparations approved a revised monograph for ORS that details this new formulation at its meeting in October 2005 to be included in the fourth edition of The International Pharmacopoeia. Furthermore, commercially available ORS products comprise sachets, ice cubes, beverages, and effervescent tablets for solution preparationthat are frequently offered and have a wide range of flavours.
MARKET SCOPE
The "Global oral rehydration salts market analysis to 2030" is a specialized and in-depth study of the pharmaceutical industry with a special focus on global market trend analysis. The report aims to provide an overview of the oral rehydration salts market with detailed market segmentation by product sales, dosage form, age group, indication, distribution channel, and geography. The report provides key statistics on the market status of the leading oral rehydration salts market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The oral rehydration salts market is segmented based on product sales, dosage form, age group, indication, distribution channel, and region. Based on product sales the global oral rehydration salts market is bifurcated into otc products and prescriptions. Based on dasage form, the oral rehydration salts market is bifurcated into a powder and liquid tablets. Based on age group, oral rehydration salts market is classified into infants, children and adults. By indication, market is segregated into diarrhea, gastroenteritis, electrolyte imbalance and others. The oral rehydration salts market is segmented by distribution channel into hospital pharmacies, retail pharmacies and online pharmacies.
MARKET DYNAMICS
Drivers-
The increasing cases of diahrea on global level favorably impact the oral rehydration salts market. According to WHO, over 1.7 million people experience diarrhea worldwide, and 760,000 children are expected to die from diarrhea associated dehydration. Regardless of the etiology or age range impacted, WHO and UNICEF have ecouranged the use of new ORS formulation for the past three decades for prevention and treatment of dehydration from diarrhea. Due to an increase in severe diarrhoea cases in childrens under age of 5 years require ORS solutions which will increase the demand for oral rehydration salts. The ORS demand is estimated by the help of national program that uses epidemiological statistics. To provide nations with a safe and reliable programme supply, UNICEF has found and is marketing high-quality co-packaged ORS and zinc, that is helping governments increase the use of these substances.
Furthermore, the pharmaceutical and healthcare industries are expanding quickly due to technological advancements, rising healthcare spending, and improved healthcare infrastructure and systems. Around the world, several clinics, ambulatory surgical centres, and hospitals are implementing various awareness programs for dehydration which will drive the oral rehydration salts market.. Global oral rehydration salts (ORS) market revenue growth is largely attributed to factors like rising chronic disease prevalence, quick advancements in healthcare and medicine, and rising public and private funding. Additionally, throughout the forecast period, rising investments in research & development activities, and rising focus on medication development are anticipated to propel global oral rehydration salts market growth.
REGIONAL FRAMEWORK
North America is expected to hold the major market share in oral rehydration salts market in 2022 owing to the rising incidences of diarrheal disease in the region. Increase in the number of health-conscious consumers in North America, growing emphasis on introducing oral electrolyte solutions with innovative packaging, and increase in sports activities, are factors expected to fuel the growth of the North America oral electrolyte solutions market. Sales growth in this industry will probably be aided by expanding the distribution network for these beverages, including supermarkets, convenience stores, and e-commerce websites. Oral electrolyte solution sales are rising due to people's changing lifestyles increasing their discretionary income and enabling them to spend more on ready-to-consume goods. Additionally, the changing lifestyles of consumers due to improved health and awareness are providing opportunities for the market growth, and manufacturers anticipate that sales of oral electrolyte solutions would rise during the projection period.
During the projection period, Asia Pacific is anticipated to grow significantly in market share for oral rehydration salts (ORS). The oral rehydration salt (ORS) market growth is driven by increased awareness of childhood malnutrition, an increase in the number of non-government organisations working to promote child health, and significant investments in children's healthcare programmes in nations like India. According to UNICEF, the prevalence of malnutrition is still extremely high, and 50% of all fatalities in children under the age of 5 yeras are related to undernutrition. The UNICEF estimates that in March 2019, 149.0 million children had stunted growth and nearly 49.0 million were underweight. Furthermore, it is envisaged that government and non-profit organizations' involvement in supplying oral electrolyte solutions will drive the oral rehydration salts market growth.
Oral Rehydration Salts Market Report Analysis
CAGR (2023 - 2031)
US$ XX Million
US$ XX Million
Report Coverage
Key Players
Regional Overview
Market Segmentation
By Product Sales
By Dosage Form
By Age Group
By Indication
The report covers key oral rehydration salts market developments, such as organic and inorganic growth strategies. Various companies such as Abbott, AstraZeneca, BoehringerIngelheim, Eli Lilly & Company, Mylan N.V., Pfizer, Depomed Inc., Endo International Plc., GlaxoSmithKline Plc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Purdue Pharma L.P., Teva Pharmaceutical Industries and among others are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market players from the oral rehydration salts market are anticipated to have lucrative growth opportunities with the rising demand for oral rehydration salts in the global market.
Key Developments in Global Oral Rehydration Salts Market
- In January 2022, The FDC brand Electral Z+ (ORS+Zinc Solution) and UFlex-Asepto, India's first aseptic liquid packaging producer, are collaborating on ready-to-drink (RTD), over-the-counter goods. Halewood Laboratories Private is the manufacturer of the formulation.
- In June 2022, Otsuka Pharmaceutical Factory launched OS-1 Apple Flavor 300 mL and 500 mL to the oral rehydration solution OS-1 series.
- In June 2021, Over 93 million zinc tablets and more than 30 million oral rehydration salt sachets were delivered by UNICEF worldwide, and the organization seeks to increase consumer access to co-packaged goods.
The report includes key companies' profiles, SWOT analysis, and oral rehydration salts market size and strategies. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information for the last three years, and key development in the past five years.
The Insight Partner’s dedicated research and analysis team comprises experienced professionals with advanced statistical expertise and offers various customization options in the current study.
Oral Rehydration Salts Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product Sales
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. ZYDUS CADILA HEALTHCARE LTD.
2. LUPIN
3. INTAS PHARMACEUTICAL
4. DR. REDDYS
5. MANKIND PHARMA
6. CIPLA LIMITED
7. OTSUKA PHARMACEUTICAL CO., LTD.
8. RECKITT BENCKISER GROUP PLC
9. SHEREYA LIFE SCIENCES PVT. LTD.
10. WALLACE PHARMA
Get Free Sample For